| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| OTC(元) | 583,123,160.08 | 1,133,729,715.05 | 911,826,139.85 |
| 处方药(元) | 635,662,283.18 | 1,131,936,930.51 | 711,552,603.45 |
| 大健康产品(元) | 11,587,956.61 | 21,648,242.62 | 14,645,781.33 |
| 其他(元) | 31,619,478.60 | 75,635,312.14 | 35,926,796.26 |
| 营业成本(元) | |||
| OTC(元) | 328,269,352.78 | 638,984,241.84 | 482,300,637.13 |
| 处方药(元) | 169,325,808.98 | 281,835,949.59 | 187,166,368.76 |
| 大健康产品(元) | - | 9,765,302.41 | - |
| 其他(元) | - | 36,409,017.22 | - |
| 毛利(元) | |||
| OTC(元) | 254,853,807.30 | 494,745,473.21 | 429,525,502.72 |
| 处方药(元) | 466,336,474.20 | 850,100,980.92 | 524,386,234.69 |
| 大健康产品(元) | - | 11,882,940.21 | - |
| 其他(元) | - | 39,226,294.92 | - |
| 毛利率(%) | |||
| OTC(%) | 43.70 | 43.64 | 47.11 |
| 处方药(%) | 73.36 | 75.10 | 73.70 |
| 大健康产品(%) | - | 54.89 | - |
| 其他(%) | - | 51.86 | - |
| 收入构成(%) | |||
| OTC(%) | 46.21 | 47.98 | 54.47 |
| 处方药(%) | 50.37 | 47.90 | 42.51 |
| 大健康产品(%) | 0.92 | 0.92 | 0.87 |
| 其他(%) | 2.51 | 3.20 | 2.15 |
| 毛利构成(%) | |||
| OTC(%) | 35.34 | 35.44 | 45.03 |
| 处方药(%) | 64.66 | 60.90 | 54.97 |
| 大健康产品(%) | 0.00 | 0.85 | 0.00 |
| 其他(%) | 0.00 | 2.81 | 0.00 |